Goodwin’s global Medtech team partners with clients across the entire corporate life cycle, helping them navigate complex legal and regulatory landscapes to bring their innovative technologies to market.
Comprised of former in-house counsel, patent examiners, and Food and Drug Administration (FDA) executives, our team combines deep industry knowledge with practical legal insight. We provide clients with business-minded legal guidance on capital markets, intellectual property (IP) strategy, licensing, FDA approvals, and compliance while offering connections to leading venture capital firms.
Clients rely on us as a one-stop resource for strategic counsel that anticipates needs and accelerates pathways to market.
Connect with our Medtech team and let us know how we can help.
Areas of Focus
We help medtech clients navigate complex transactions, from early venture funding to initial public offerings, and establish governance practices that set a solid foundation for growth.
We help clients safeguard and maximize their IP assets worldwide, whether it’s medical device implants, artificial intelligence–powered diagnostics, or other advanced technologies.
Our team brings knowledge of deal terms, trends, and industry drivers to structure complex transactions that align with clients’ strategic goals.
Drawing on deep FDA and medtech industry experience, our team guides clients through compliance and regulatory matters, addressing critical issues like fraud, privacy, and compliance program development.
Contacts
.
- /en/people/b/bluni-scott
Scott Bluni
Partner - /en/people/h/havranek-kristin
Kristin Havranek
Partner - /en/people/w/wetzel-matt
Matt Wetzel
PartnerLife Sciences Regulatory & Compliance - /en/people/b/brown-d-kristopher
Kristopher D. Brown
Partner - /en/people/r/rich-deepa
Deepa M. Rich
Partner
